HLA Group - Public Comps and Valuation Multiples

HLA Group Overview

About HLA Group

Hla Group Corp Ltd is a Chinese clothing company. Its businesses include the operation of brand clothes, the production, and sales of upscale suits and professional clothing. Its brand clothing management includes brand management, supply chain management, and marketing network management. The company operates product brands including HLA, HLA Group Buying, OVV, Yingshi YeeHoO, and HLA Optimal Selection. The company offers men's clothing, women's clothing, and accessories.

Founded

1997

HQ

Employees

26.1K+

Website

hla.com.cn

Sectors

Clothing & Accessories

Financials

LTM Revenue $3.1B

LTM EBITDA $562M

EV

$3.5B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

HLA Group Financials

As of September 2025, HLA Group reported last 12-month revenue of $3.1B and EBITDA of $562M.

In the same period, HLA Group generated $1.4B in LTM gross profit and $332M in net income.

See HLA Group valuation multiples based on analyst estimates

HLA Group P&L

In the most recent fiscal year, HLA Group reported revenue of $2.9B and EBITDA of $583M.

HLA Group expects next 12-month revenue of XXX and NTM EBITDA of XXX

See HLA Group valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$3.1B	XXX	$2.9B	XXX	XXX	XXX
Gross Profit	$1.4B	XXX	$1.3B	XXX	XXX	XXX
Gross Margin	45%	XXX	45%	XXX	XXX	XXX
EBITDA	$562M	XXX	$583M	XXX	XXX	XXX
EBITDA Margin	18%	XXX	20%	XXX	XXX	XXX
EBIT	$431M	XXX	$431M	XXX	XXX	XXX
EBIT Margin	14%	XXX	15%	XXX	XXX	XXX
Net Profit	$332M	XXX	$303M	XXX	XXX	XXX
Net Margin	11%	XXX	10%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for HLA Group including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $3.1B. EBITDA for the last twelve months was $562M. In the most recent fiscal year, HLA Group achieved $2.9B in revenue and $583M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$3.1B	Analyst estimates available to subscribers	$2.9B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$1.4B	Analyst estimates available to subscribers	$1.3B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	44.7% gross margin	Analyst estimates available to subscribers	44.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$562M	Analyst estimates available to subscribers	$583M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	18.2% EBITDA margin	Analyst estimates available to subscribers	19.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$431M	Analyst estimates available to subscribers	$431M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	14.0% EBIT margin	Analyst estimates available to subscribers	14.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$332M	Analyst estimates available to subscribers	$303M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	10.8% net profit margin	Analyst estimates available to subscribers	10.3% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for HLA Group

This financial data table provides comprehensive performance metrics for HLA Group, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

HLA Group generated $3.1B in revenue over the last twelve months.
The company achieved $562M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $1.4B.
Net income over the last twelve months reached $332M.

Fiscal Year Performance

In the most recent fiscal year, HLA Group reported $2.9B in total revenue.
Fiscal year EBITDA was $583M.
The company maintained a gross profit margin of 44.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 19.8%.
Net profit margin reached 10.3% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for HLA Group. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

HLA Group Stock Performance

HLA Group has current market cap of CNY 31.5B (or $4.4B), and EV of CNY 25.1B (or $3.5B).

Market Cap Evolution

HLA Group Stock Data

As of October 17, 2025, HLA Group's stock price is CNY 7 (or $1).

See HLA Group trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$3.5B	$4.4B	XXX	XXX	XXX	XXX	$0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

HLA Group Valuation Multiples

HLA Group's trades at 1.2x EV/Revenue multiple, and 6.1x EV/EBITDA.

See valuation multiples for HLA Group and 15K+ public comps

HLA Group Financial Valuation Multiples

As of October 17, 2025, HLA Group has market cap of $4.4B and EV of $3.5B.

Equity research analysts estimate HLA Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

HLA Group has a P/E ratio of 13.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$4.4B	XXX	$4.4B	XXX	XXX	XXX
EV (current)	$3.5B	XXX	$3.5B	XXX	XXX	XXX
EV/Revenue	1.1x	XXX	1.2x	XXX	XXX	XXX
EV/EBITDA	6.3x	XXX	6.1x	XXX	XXX	XXX
EV/EBIT	8.2x	XXX	8.2x	XXX	XXX	XXX
EV/Gross Profit	2.6x	XXX	n/a	XXX	XXX	XXX
P/E	13.3x	XXX	14.6x	XXX	XXX	XXX
EV/FCF	6.6x	XXX	13.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get HLA Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

HLA Group Margins & Growth Rates

HLA Group's last 12 month revenue growth is 9%

HLA Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $34K for the same period.

HLA Group's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

HLA Group's rule of X is 42% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for HLA Group and other 15K+ public comps

HLA Group Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	9%	XXX	8%	XXX	XXX	XXX
EBITDA Margin	18%	XXX	20%	XXX	XXX	XXX
EBITDA Growth	12%	XXX	-11%	XXX	XXX	XXX
Rule of 40	33%	XXX	29%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	42%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$34K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	11%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	30%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial